Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 9 | 2024 | 400 | 2.030 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 4 | 2024 | 44 | 1.910 |
Why?
|
| Microbubbles | 5 | 2024 | 38 | 1.420 |
Why?
|
| Mice, Nude | 9 | 2024 | 816 | 1.160 |
Why?
|
| Doxorubicin | 3 | 2024 | 293 | 1.100 |
Why?
|
| Capillary Permeability | 2 | 2024 | 132 | 0.950 |
Why?
|
| Apoptosis | 5 | 2024 | 1718 | 0.800 |
Why?
|
| Receptors, Notch | 2 | 2018 | 126 | 0.670 |
Why?
|
| Hemolysin Proteins | 1 | 2018 | 34 | 0.630 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 69 | 0.620 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 114 | 0.600 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 278 | 0.500 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2014 | 13 | 0.460 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 62 | 0.450 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 901 | 0.400 |
Why?
|
| Phantoms, Imaging | 3 | 2024 | 462 | 0.390 |
Why?
|
| Signal Transduction | 3 | 2019 | 3403 | 0.350 |
Why?
|
| Neovascularization, Pathologic | 5 | 2015 | 354 | 0.340 |
Why?
|
| Mice | 11 | 2024 | 11851 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2023 | 405 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 565 | 0.320 |
Why?
|
| Ultrasonography | 5 | 2024 | 720 | 0.300 |
Why?
|
| Animals | 15 | 2024 | 27526 | 0.260 |
Why?
|
| Diabetic Retinopathy | 2 | 2019 | 91 | 0.260 |
Why?
|
| Hypoxia | 2 | 2023 | 657 | 0.240 |
Why?
|
| Heterografts | 2 | 2023 | 102 | 0.240 |
Why?
|
| Ultrasonic Therapy | 1 | 2024 | 37 | 0.230 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 112 | 0.230 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2587 | 0.220 |
Why?
|
| Perfusion Imaging | 2 | 2020 | 50 | 0.200 |
Why?
|
| Nitric Oxide | 1 | 2023 | 280 | 0.190 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 94 | 0.190 |
Why?
|
| Acoustics | 1 | 2021 | 51 | 0.190 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 124 | 0.170 |
Why?
|
| Retinol-Binding Proteins | 1 | 2019 | 8 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 700 | 0.160 |
Why?
|
| ADAM10 Protein | 1 | 2018 | 7 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 485 | 0.150 |
Why?
|
| Eye Proteins | 1 | 2019 | 128 | 0.150 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2018 | 95 | 0.150 |
Why?
|
| Retina | 1 | 2019 | 220 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 476 | 0.140 |
Why?
|
| Humans | 14 | 2024 | 89925 | 0.140 |
Why?
|
| Lymphatic Abnormalities | 1 | 2016 | 8 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 272 | 0.130 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 198 | 0.130 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 104 | 0.130 |
Why?
|
| Contrast Media | 3 | 2020 | 1084 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 87 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1227 | 0.110 |
Why?
|
| Colon | 1 | 2016 | 521 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2012 | 293 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 690 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 744 | 0.100 |
Why?
|
| Tomography, Optical | 1 | 2012 | 9 | 0.100 |
Why?
|
| Sarcoma, Ewing | 1 | 2012 | 44 | 0.100 |
Why?
|
| Polyethyleneimine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Maleimides | 1 | 2011 | 26 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2012 | 118 | 0.090 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 153 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1180 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 269 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1864 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2012 | 952 | 0.080 |
Why?
|
| Female | 6 | 2023 | 46572 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 755 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2023 | 464 | 0.080 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 57 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 716 | 0.070 |
Why?
|
| Biomarkers | 1 | 2014 | 1775 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2019 | 79 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 665 | 0.060 |
Why?
|
| Polyethylene Glycols | 2 | 2020 | 360 | 0.060 |
Why?
|
| Kidney | 2 | 2024 | 1148 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 3252 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1576 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2023 | 88 | 0.050 |
Why?
|
| DNA | 2 | 2023 | 1311 | 0.050 |
Why?
|
| Perfusion | 1 | 2023 | 253 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 6408 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 3021 | 0.050 |
Why?
|
| Bevacizumab | 2 | 2012 | 268 | 0.050 |
Why?
|
| Blood Volume Determination | 1 | 2020 | 14 | 0.040 |
Why?
|
| Ultrasonic Waves | 1 | 2020 | 5 | 0.040 |
Why?
|
| Photoacoustic Techniques | 1 | 2020 | 7 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2023 | 372 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 435 | 0.040 |
Why?
|
| 3-O-Methylglucose | 1 | 2019 | 2 | 0.040 |
Why?
|
| Ependymoglial Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2019 | 9 | 0.040 |
Why?
|
| Acids | 1 | 2019 | 13 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 2019 | 37 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2019 | 197 | 0.040 |
Why?
|
| Protective Agents | 1 | 2019 | 34 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2019 | 54 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 73 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1469 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 178 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 135 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 135 | 0.040 |
Why?
|
| Child | 2 | 2023 | 7242 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 785 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1255 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 368 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1008 | 0.040 |
Why?
|
| Pericytes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 3065 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 303 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 84 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 786 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 277 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 327 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 208 | 0.030 |
Why?
|
| Collagen | 1 | 2016 | 294 | 0.030 |
Why?
|
| Male | 2 | 2016 | 42658 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 200 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 26133 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2015 | 468 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1250 | 0.030 |
Why?
|
| Adult | 1 | 2014 | 26811 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 361 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 520 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2767 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1091 | 0.030 |
Why?
|
| Plant Lectins | 1 | 2012 | 10 | 0.020 |
Why?
|
| Blood Volume | 1 | 2012 | 49 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2012 | 30 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1704 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 806 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 193 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 291 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 591 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 245 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 899 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2887 | 0.020 |
Why?
|
| Receptor, Notch4 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2008 | 6 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2008 | 46 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 173 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 303 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 121 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 371 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 692 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 182 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 5357 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 793 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 1048 | 0.020 |
Why?
|
| United States | 1 | 2018 | 7102 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 589 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1801 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 3796 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3470 | 0.010 |
Why?
|